Vaccines, Blood & Biologics

PROVENGE® (sipuleucel-T)

STN: BL 125197
Proper Name: Autologous Cellular Immunotherapy
Tradename: PROVENGE^®
Manufacturer: Dendreon Corporation

Indication:

For the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

Questions and Answers - Provenge
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.

(800) 835-4709

(301) 827-1800

Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

1401 Rockville Pike

Suite 200N/HFM-47

Rockville, MD 20852-1448